Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 22 Prostatic Neoplasms 11 Osteoporosis 8 Vitamin D Deficiency 7 Polycystic Ovary Syndrome 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Colonic Neoplasms 5 Neoplasms 4 Obesity 3 Neoplasm Metastasis 3 Lung Neoplasms 3 Inflammation 3 Colorectal Neoplasms 3 Carcinoma, Hepatocellular 3 Bone Diseases, Metabolic 3 Multiple Endocrine Neoplasia Type 1 2 Motor Activity 2 Lymphoma 2 Leukemia 2 Leiomyoma 2 Giant Cell Tumor of Bone 2 Gastrointestinal Neoplasms 2 Cardiovascular Diseases 2 Carcinoma, Transitional Cell 2 Brain Neoplasms 2 Bone Diseases 2 Warts 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1

Interventions

pembrolizumab 3 Paclitaxel 2 relatlimab 1 nintedanib 1 lifileucel 1 dabrafenib 1 Vitamin D 1 Temozolomide 1 Surveys and Questionnaires 1 Opdualag 1 Nivolumab 1 Microarray Analysis 1 Ipilimumab 1 Genetic Testing 1 Gene Expression Profiling 1 Eye Movement Desensitization Reprocessing 1 Electrochemotherapy 1 Dacarbazine 1 Cholecalciferol 1 Carboplatin 1 Biopsy 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma, Cutaneous Malignant × Vitamin D × Clear all

NCT01748448 2025-02-17

ViDMe

Universitaire Ziekenhuizen KU Leuven

Phase 3 Completed

436 enrolled 16 charts

Melanoma, Cutaneous Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡